| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |